Immediate Impact
5 hit
Citing Papers
Primary myelofibrosis: 2023 update on diagnosis, risk‐stratification, and management
2023 Hit
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
2022 Hit
Works of Ni‐Chun Tsai being referenced
Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label study
2021
Repurposing leflunomide for relapsed/refractory multiple myeloma: a phase 1 study
2020